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Wounds with full-thickness skin loss are commonly managed by skin grafting. In the absence of a graft, reepithelialization is
imperfect and leads to increased scar formation. Biomaterials can alter wound healing so that it produces more regenerative tissue
and fewer scars. This current study use the new chitosan based biomaterial in full-thickness wound with impaired healing on rat
model. Wounds were evaluated after being treated with a chitosan dermal substitute, a chitosan skin substitute, or duoderm CGF.
Wounds treated with the chitosan skin substitute showed the most re-epithelialization (33.2 ± 2.8%), longest epithelial tongue (1.62
± 0.13mm), and shortest migratory tongue distance (7.11 ± 0.25mm). The scar size of wounds treated with the chitosan dermal
substitute (0.13 ± 0.02 cm) and chitosan skin substitute (0.16 ± 0.05 cm) were significantly decreased (𝑃 < 0.05) compared with
duoderm (0.45 ± 0.11 cm). Human leukocyte antigen (HLA) expression on days 7, 14, and 21 revealed the presence of human hair
follicle stem cells and fibroblasts that were incorporated into and surviving in the irradiated wound.We have proven that a chitosan
dermal substitute and chitosan skin substitute are suitable for wound healing in full-thickness wounds that are impaired due to
radiation.
1. Introduction
Wound healing is a complex biological process that involves
molecular and cellular responses. The function of wound
healing is to rapidly and functionally produce skin layers and
appendages that are free of scars and as physiologically fit as
native skin. The reconstruction of skin after injury involves
different types of wound healing depending on the wound
classification. For example, skin with a superficial loss of
the epidermis gradually heals over time without interven-
tion. In a partial-thickness wound, the epidermis primarily
heals by re-epithelialization, which is the resurfacing of a
wound bed by neokeratinocytes. In a surgical setting, partial-
thickness wounds heal by primary intention, also known as
surgical wound healing.This type of healing employs sutures,
staples, glue, or strips between both sides of the wound edge
to close the wound bed. The major events in healing by
primary intention are connective tissue deposition and re-
epithelialization. There is no formation of granulation tissue
or wound contraction [1].
Wounds with a full-thickness loss of the dermis and epi-
dermis cannot be repaired by primary intention. In the case
where a large amount of skin is removed or destroyed, a gap
occurs in the wound or a nonviable woundmargin is present.
As a result, the wound edges cannot be approximated. The
presence of a wound gap prevents re-epithelialization. In this
case, wounds can only heal by grafting epidermis over the
wounded area. In the absence of a graft, the wound will
2 BioMed Research International
(a)
Hair follicle
Sebaceous gland
(b)
Hair
Hair follicle
Sebaceous gland
(c)
Figure 1: Radiation-induced temporary hair loss at dorsal area (a). Hematoxylin and Eosin (H&E) stained images of irradiated rat (b) and
nonirradiated rat (c). Irradiated skin has no hair; anatomical and functional changes in hair follicles and sebaceous glands. Scale bar: (a) 3 cm,
(b) and (c): 200 𝜇m.
reepithelialize slowly and imperfectly via the ingrowths of
cell from the wound edges, which leads to increased scar
formation.
However, biomatrices may be an alternative to a graft.
Biomatrices are made of biopolymers that are often resorbed
or degraded in the body and are regularly used in therapeutic
applications [2], especially in skin tissue engineering. With
biomatrices, wound healing can be manipulated to produce
more regenerative tissue than scar tissue [3]. Biomatrices or
cell-biomatrix constructs create the optimal conditions for
accelerated wound healing which result in less or no scar for-
mation and easy handling for transplantation and replaces the
use of skin grafts. In the current study, full-thickness wounds
with impaired healing were treated with three biomaterials:
a chitosan dermal substitute, a chitosan skin substitute, and
duoderm CGF. Wounds were then histomorphometrically
evaluated. We concluded that the chitosan dermal substitute
and chitosan skin substitute contributed to the accelerated
wound healing in irradiated rats.
2. Materials and Methods
This research was approved by the Animal Ethics Committee
of Universiti Sains Malaysia. Approval code: USM/Animal
Ethics Approval/2009/(44)(133).The animal procedures were
conducted in accordance with the guidelines of the Animal
Research and Service Centre, USM.
2.1. Animal Radiation. Three-month-old male Sprague Daw-
ley rats, weighing 300–350 g, were randomized into three
groups based on postwound time frames of 7, 14 or 21 days
(𝑛 = 5 each). The rats were housed in separate cages at
22∘C–26∘C and alternating 12-hour light and dark cycles in
a controlled room. The rats were fed a standard laboratory
diet and water ad libitum. Prior to radiation, the rats were
anesthetized with an intramuscular injection of ketamine
(100mg/kg) and xylazine (20mg/kg). The dorsal area was
shaved and marked. Skin irradiations were carried out using
the source-skin distance technique (SSD)with a 6MVphoton
beam from a linear accelerator (Siemens Primus, Germany).
A SSD at 100 cmwith a gantry angle of 0∘, a collimator 0∘, and
a radiation field size of 3 cm × 10 cm was performed on the
dorsum of each rat.The dorsum of each rat was given a single
dose of 10Gy. A 1.5 cm tissue-equivalent bolus ofmaterial was
placed over the dorsal area to bring the full radiation dose to
the skin surface [4, 5].
2.2. Biomaterials. Three bio-templates for skin regeneration
were used: a chitosan dermal substitute, a chitosan skin
substitute, and duoderm CGF. The chitosan sponge was
fabricated as previously described [6]. In this study, it is
named as chitosan dermal substitute. It was produced from
ultrapure medical-grade chitosan powders of prawn shell.
Chitosan powders were irradiated with 10 kGy of gamma
radiation to produce a molecular weight of 440,000 Daltons
and dissolved in 0.5M acetic acid which formed a solution.
To obtain a sponge layer, the chitosan solution is poured into
a 10 cm by 10 cm polytetrafluoroethylene (PTFE)mold, deep-
frozen at −20∘C for 24 hours and freeze drying for 20 hours.
Duoderm CGF is commercially produced (Convatec, USA).
It composed of gel andmatrix layers. To fabricate the chitosan
skin substitute, chitosan sponge matrices were seeded with
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Figure 2: H&E stained images of irradiated and nonirradiated wounds on day 7. The square dotted line indicates the epithelial tongue (ET).
The dash dotted line shows the area between wound edge and unwounded skin. Scale bar: 500 𝜇m. (SG: sebaceous gland, HF: hair follicle).
human dermal fibroblasts at a density of 3 × 106/cm2 for
two weeks, followed by being co-cultured or one week with
primary human hair follicle stem cells (HFSCs) at a density of
1×10
6/cm2.The isolation of HFSCs was described previously
[7]. Briefly, the dermis containing hair follicle was incubated
in 0.1% (w/v) collagenase type I (Gibco, USA) before being
cultured in CnT-07 medium (CellnTech, Switzerland). The
coculture was performed using a combination of Dulbecco’s
Modified Eagle Medium/Ham’s F12 (DMEM/F12) (Invitro-
gen, USA) and supplemented with 5% fetal bovine serum
(FBS) (Invitrogen, USA) and CnT-07 medium at ratio of 1 : 2.
After three weeks in culture, the chitosan skin substitute was
harvested for wound healing experiments.
2.3. Wound Creation. Two months postradiation, three full-
thicknesses wounds 1 cm by 1 cm in size were excised on the
irradiated dorsum of each rat. Prior to incision, the rats were
anesthetized with an intramuscular injection of ketamine
(100mg/kg) and xylazine (20mg/kg). The fur on the dorsal
skin was shaved.The shaved area was scrubbed and sterilized
with 70% alcohol and then sprayed with povidone-iodine.
Animals were placed on a heated surgery table and incisional
wound was created using a sterile scalpel and blade (size 10).
Each of the wounds was randomly covered with one of the
three different types of biomaterials as mentioned above.
2.4. Histomorphometrical Analysis. To determine the length
of the epithelial tongue, the distance of the migratory tongue,
and the scar size, a computer-based histological image
analysis (𝑛 = 5) was performed using the Mirax Viewer
(Zeiss, Germany). The scar size was measured between the
gaps in granulation tissues as mentioned previously [8]
with modification. The percentage of re-epithelialization was
measured as the ratio of the neoepidermis and thewound area
[9]. The percentage of the wound size was calculated as the
ratio of the wound size at day x over the wound size at day 0
[10].
2.5. Wound Assessment. The wound assessment was per-
formed without removing the biomaterials or cleaning the
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Figure 3: H&E stained images of irradiated and nonirradiated wounds on day 7. The arrow head indicates the epithelial tongue. The dash
dotted lines show the outline of the migratory tongue (MT) distance. All biomaterials were adsorbed in wound bed in nonirradiated group
((d), (e), (f)). Scale bar: 200 𝜇m.
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BioMed Research International 5
Scar
Granulation tissue
Neo-dermis
Irradiated
Ch
ito
sa
n 
sk
in
 su
bs
tit
ut
e
Neo-dermis
Scar
Granulation tissue
Nonirradiated
Neo-dermis
Granulation tissue
Scar
Ch
ito
sa
n 
de
rm
al
 su
bs
tit
ut
e
Granulation tissue
Scar
Neo-dermis
Granulation tissue
Neo-dermis
Scar
D
uo
de
rm
 C
G
F Neo-dermis
Scar
Granulation tissue
(a)
(b)
(c)
(d)
(e)
(f)
Figure 5: H&E stained images of irradiated and nonirradiated wounds on day 21. The double-headed arrows indicate the width of the scar.
The dashed lines show the outline of the neodermis regeneration and granulation tissue. Scale bar: 1000 𝜇m.
debris from the wound bed during the healing process. Seven
parameters were assessed on days 7, 14, and 21 using the
following scoring system: infection (pus), 1 if absent or 2 if
present; hematoma, 1 If absent or 2 if present; exudates, 1 if
high, or 2 if intermediate, or 3 if low; odor, 1 if strong, or 2
if intermediate, or 3 if none; flexibility, 0 if not flexible or 3
if flexible; adherence of biomaterials, 0 if nonadherent or 3
if adhered strongly; and fluid accumulation on biomaterials,
0 if yes or 3 if no. Scoring was based on the wound edge
because the wound bed was covered with permanent tissue-
engineered biomaterials.
2.6. Dressing. Secondary wound dressings were performed
usingHypafix (BSNMedical, Germany) andTgfix (Lohmann
& Rauscher, Germany). Prior to the dressing, the rats were
anesthetized with inhaled isoflurane. To avoid attaching
the biomaterials to the Hypafix which causes tears in the
biomaterials after removing the Hypafix, gauze was used to
cover the sticky side of a 1 cm by 1 cm piece of opsite flexi
grid (Smith & Nephew, England) and this was applied over
the biomaterial. Tg fix was used as a second layer of dressing
before the wounds were covered with a bandage. The wound
dressing was changed every three days.
2.7. Wound Evaluation. Rats in each group were sacrificed
on postoperative days 7, 14, or 21 with an intramuscular
injection of an over dose of ketamine (100mg/kg) and
xylazine (20mg/kg). Images of the wounds were captured
and measured before the wounds were excised. The excised
area included the wound bed and intact skin and was then
fixed with 10% formalin before histological analysis using
H&E staining. The images of stained samples were captured,
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Figure 6: Expression of K10 along themigratory tongue. On day 7 postwound, there is no expressions in the irradiated rat ((b), (c)). However,
the wound with chitosan skin substitute slightly expressed K10 (a with asterisk), and the nonirradiated rat showed similar results ((d), (e),
(f)). K10 started to be slightly expressed in the irradiated rat on day 14 ((g), (h), (i)). K10 was highly expressed on day 14 in the nonirradiated
rat ((j), (k), (l)) and on day 21 in the irradiated rat ((m), (n), (o)). The nonirradiated rats continuously expressed K10 on day 21 ((p), (q), (r)).
Scale bar: 20 𝜇m. (E: epidermis, D: dermis).
measured, and analyzed using a Mirax Desk Scanner (Zeiss,
Germany).
2.8. Immunofluorescence. Immunofluorescent staining was
performed on paraffin-embedded sections. Sections were
placed on hot plate for two hours, deparaffinized in xylene,
and rehydrated using a graded series of 100, 95, 80, 70,
and 50% ethanol followed by distilled water. Pretreatment
was performed using a water bath containing a target
retrieval solution (pH 9) (Dako, Denmark) at 98∘C for
15 minutes. Evaluation of the human tissue engrafted into
the wound bed was performed using mouse monoclonal
antibodies against human HLA (1 : 100) (Abcam, UK) or rat
K10 (1 : 500) (Abcam, UK) for evaluation of the proliferation
of the neoepidermis. To block nonspecific antibody-antigen
binding, sections were preincubated with 10% normal serum
in tris-buffered saline (TBS) for 20 minutes. Incubation
with a primary antibody was performed at 4∘C overnight.
Sections were incubated with a fluorescent goat polyclonal
secondary antibody against mouse IgG at room temperature
for 45minutes. Nuclei were counter stainedwithDAPI. Slides
weremounted with fluoromount-G (Southern Biotech, USA)
and viewed under Axioplant2 fluorescent microscope (Zeiss,
Germany).
2.9. Statistics . Thedata on physical observation are presented
as the means ± SEM.The rest, an ANOVA was used for anal-
yses. A significant difference was considered when 𝑃 < 0.05.
Bonferroni test was used to identify statistically significant
differences between specific intergroup mean values.
3. Results
Postradiation symptoms in rats can be observed physically
and histologically (Figure 1). During the proliferation stage
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Figure 7: HLA (green fluorescence) was incorporated into wounds on days 7 ((a), (d)), 14 ((b), (e)), and 21 ((c), (f)). The positive control of
human skin (g). The negative control of chitosan dermal substitute-treated wounds (h) and duoderm-treated wounds (i). The epidermis and
dermis are demarcated via the dash dotted lines. Nuclei stained blue. Scale bar: 20 𝜇m.
at day 7, the migratory tongue distance (MT), the epithelial
tongue (ET), and re-epithelialization were analyzed for both
the irradiated and nonirradiated groups.The ET in irradiated
wounds treated with a chitosan skin substitute was longer
(1.62 ± 0.13mm) than those in the irradiated wounds treated
with a chitosan dermal substitute (1.22 ± 0.19mm) or
duoderm (1.14±0.18mm) (𝑃 = 0.20 and𝑃 = 1.0, resp.) In the
nonirradiated wounds, the ET was longer after wounds were
treated with a chitosan dermal substitute (1.23 ± 0.12mm)
compared to a chitosan skin substitute (1.19 ± 0.21mm) or
duoderm (1.11 ± 0.30mm) (Figure 2) (𝑃 = 1.0).
The MT distances in irradiated wounds treated with
chitosan skin substitutes were shorter (7.11 ± 0.25mm) than
irradiated wounds treated with a chitosan dermal substitute
(8.16 ± 0.26mm) or duoderm (7.25 ± 0.47mm) (𝑃 = 1.0 and
𝑃 = 0.26, resp.). In nonirradiated wounds, the MT distances
were shorter in wounds that were treated with duoderm
(5.61 ± 0.71mm) compared to the chitosan skin substitute
(7.23 ± 0.47mm) or the chitosan dermal substitute (5.90 ±
0.61mm) (Figure 3) (𝑃 = 0.24 and 𝑃 = 1.0, resp.).
There was greater re-epithelialization in the irradiated
wounds treated with the chitosan skin substitute (33.2 ±
2.8%) than those treated with the chitosan dermal substitute
(26.8 ± 4.8%) or duoderm (25.7 ± 3.7%) (𝑃 = 0.577 and 𝑃 =
1.0, resp.). In nonirradiated wounds, the re-epithelialization
was higher after wounds were treated with the chitosan
dermal substitute (32.5±3.1%) compared to the chitosan skin
substitute (27.4 ± 4.1%) or duoderm (27.2 ± 6.3%) (𝑃 = 1.0)
(Figure 4(a)).
Between day 7 and day 21, nonirradiated wound sizes
were decreased after coverage with skin substitutes. In irra-
diated wounds, the chitosan skin substitute was associated
with a complete repair of the full-thickness wounds by day 21.
Conversely, duoderm CGF was found to increase the wound
size on day 21 compared to day 14. It was suggested that
duoderm CGF cannot be used for long-term dressings for
impaired healing (Figure 4(b)). Duoderm CGF can only be
used for temporary primary dressing.
During the remodeling stage, sampled on day 21, the
chitosan dermal substitutes and chitosan skin substitutes
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Figure 8: Macroscopic wound healing analysis in the irradiated (a) and nonirradiated wounds (b). On day 7, the wounds enlarged compared
to day 0 due to inflammation. On day 14, the biomaterials adsorbed in (b) and the scars were clearly seen. Conversely, the biomaterials remain
incorporated in (a). On day 21, a few wounds showed incomplete epithelialization presented with scab. The arrows showed the wound area.
Scale bar 1 cm. (S: Scab).
significantly contributed to the acceleration of wound repair
in impaired healing when compared to duoderm in terms
of scar size (𝑃 = 0.039 and 𝑃 = 0.023, resp.). The scar
size was smaller in wounds treated with the chitosan dermal
substitute (0.13 ± 0.02 cm) and the chitosan skin substitute
(0.16 ± 0.05 cm). However, with duoderm, the scars were
longer (0.45 ± 0.11 cm). In nonirradiated wounds, treatment
with the chitosan skin substitute was associated with smaller
scar sizes (0.18 ± 0.04 cm) than those in wounds treated with
the chitosan dermal substitute (0.22 ± 0.04 cm) or duoderm
(0.23 ± 0.08 cm) (Figure 5). However, the difference was not
significant (𝑃 = 1.0).
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Table 1: Physical observation of irradiated wounds after treatment with three biomaterials.
Assessment (Score) Mean ± SEM
Day 7 Day 14 Day 21
Infection-pus
Chitosan skin substitute 1.0 ± 0 1.0 ± 0 1.0 ± 0
Chitosan dermal substitute 1.0 ± 0 1.0 ± 0 1.0 ± 0
Duoderm CGF 1.0 ± 0 1.0 ± 0 1.0 ± 0
Hematoma
Chitosan skin substitute 1.0 ± 0 1.2 ± 0.20 1.0 ± 0
Chitosan dermal substitute 1.0 ± 0 1.0 ± 0 1.0 ± 0
Duoderm CGF 1.0 ± 0 1.0 ± 0 1.0 ± 0
Exudation
Chitosan skin substitute 3.0 ± 0 3.0 ± 0 3.0 ± 0
Chitosan dermal substitute 3.0 ± 0 3.0 ± 0 3.0 ± 0
Duoderm CGF 3.0 ± 0 3.0 ± 0 3.0 ± 0
Odor
Chitosan skin substitute 3.0 ± 0 3.0 ± 0 3.0 ± 0
Chitosan dermal substitute 3.0 ± 0 3.0 ± 0 3.0 ± 0
Duoderm CGF 3.0 ± 0 3.0 ± 0 3.0 ± 0
Flexibility
Chitosan skin substitute 2.4 ± 0.24 2.4 ± 0.24 3.0 ± 0
Chitosan dermal substitute 2.2 ± 0.20 2.4 ± 0.24 2.4 ± 0.24
Duoderm CGF 2.00 ± 0 2.4 ± 0.24 2.4 ± 0.24
Adherence
Chitosan skin substitute 2.8 ± 0.20 1.8 ± 0.73 0.6 ± 0.60
Chitosan dermal substitute 3.0 ± 0 1.8 ± 0.73 1.2 ± 0.73
Duoderm CGF 2.4 ± 0.24 2.4 ± 0.60 1.8 ± 0.73
Fluid accumulation
Chitosan skin substitute 3.0 ± 0 3.0 ± 0 3.0 ± 0
Chitosan dermal substitute 3.0 ± 0 3.0 ± 0 3.0 ± 0
Themeans were not significantly different between biomaterials (P> 0.05).
K10 expression along the migratory tongue was assessed
on days 7, 14, and 21 (Figure 6). The mode of expression was
different between irradiated and nonirradiated wounds. HLA
expression on irradiated and nonirradiated wounds treated
with the chitosan skin substitute was determined on days 7,
14, and 21 (Figure 7).
From physical observation, chitosan dermal substitute
and chitosan skin substitute contributed to the acceleration
of healing processes both in irradiated andnonirradiated full-
thickness wounds with no pus, no haemorrhages, scant exu-
dates, no odour, and no fluid accumulation while remaining
in place (adhered to the wound) and retaining their flexibility
(elasticity with motion) as shown in Tables 1 and 2. The
events of wound healing were macroscopically summarized
in Figure 8.
4. Discussion
Radiation of rat skin at a high dose creates an ulcer that
exhibits impaired wound repair. Histologically, irradiated
skin has increased pigmentation, thickening, and fibrosis
of the skin as well as alterations in sebaceous gland func-
tion. The resulting radiation damage affects the fibroblasts,
keratinocytes and blood vessels and ultimately leads to
skin hypoxia. Necrosis and tumorigenesis are further conse-
quences of this impairment [11].
Full-thickness wounds are characterized by the
destruction of the regenerative epithelial component.
This type of wound heals by concurrent contraction and
re-epithelialization. All excessive full-thickness wounds
require skin grafting, as they show slow re-epithelialization.
A lack of skin grafting can lead to extensive scarring with
poor cosmetic and functional outcomes. Skin grafting
creates damage at the donor site which generally heals with
little scarring. The procedure causes pain at the donor site
in addition to pain at the site of skin injury. Therefore,
biomaterials for skin replacement are the best strategy for
wound management in cases of excessive skin loss.
Our analyses have shown that the re-epithelialization in
nonirradiated wounds was higher than that in irradiated
wounds, but not in wounds with the chitosan skin substitute.
This supports the conclusion that HFSCs, which play an
important function in wound healing, do not normally
respond in the healing process [12]. Re-epithelialization
consists of the formation of a new epidermis by the syn-
thesis of neokeratinocytes across a wound surface [13]. Re-
epithelialization of a full-thickness wound occurs only at
the edges of the wound and involves thickening and rolling
beneath the edges. If the cells cannot continue to migrate
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Table 2: Physical observation of nonirradiated wounds after treatment with three biomaterials.
Assessment (Score) Mean ± SEM
Day 7 Day 14 Day 21
Infection-pus
Chitosan skin substitute 1.0 ± 0 1.0 ± 0 1.0 ± 0
Chitosan dermal substitute 1.0 ± 0 1.0 ± 0 1.0 ± 0
Duoderm CGF 1.0 ± 0 1.0 ± 0 1.0 ± 0
Hematoma
Chitosan skin substitute 1.0 ± 0 1.3 ± 0.33 1.0 ± 0
Chitosan dermal substitute 1.0 ± 0 1.3 ± 0.33 1.0 ± 0
Duoderm CGF 1.0 ± 0 1.3 ± 0.33 1.0 ± 0
Exudation
Chitosan skin substitute 3.0 ± 0 3.0 ± 0 3.0 ± 0
Chitosan dermal substitute 3.0 ± 0 3.0 ± 0 3.0 ± 0
Duoderm CGF 3.0 ± 0 3.0 ± 0 3.0 ± 0
Odor
Chitosan skin substitute 3.0 ± 0 3.0 ± 0 3.0 ± 0
Chitosan dermal substitute 3.0 ± 0 3.0 ± 0 3.0 ± 0
Duoderm CGF 3.0 ± 0 3.0 ± 0 3.0 ± 0
Flexibility
Chitosan skin substitute 2.00 ± 0 2.7 ± 0.33 2.6 ± 0.24
Chitosan dermal substitute 1.8 ± 0.20 3.0 ± 0 2.6 ± 0.24
Duoderm CGF 2.4 ± 0.24 3.0 ± 0 2.4 ± 0.24
Adherence
Chitosan skin substitute 3.0 ± 0 2.0 ± 1.0 3.0 ± 0
Chitosan dermal substitute 3.0 ± 0 2.0 ± 1.0 3.0 ± 0
Duoderm CGF 2.4 ± 0.60 2.0 ± 1.0 3.0 ± 0
Fluid accumulation
Chitosan skin substitute 2.8 ± 0.20 2.0 ± 1.0 3.0 ± 0
Chitosan dermal substitute 3.0 ± 0 2.0 ± 1.0 3.0 ± 0
Themeans were not significantly different between biomaterials (P> 0.05).
across the wound bed, they build up an epithelial tongue
along the edges of the wound (Figure 2) [14]. Immediately
after-injury, epithelial cells start to migrate and change their
phenotype. Epithelial cell mitosis is active in the migrat-
ing epithelial tongue and unwounded epidermis [15]. As a
result, the migrating cells increase and the epithelial tongue
develops. The migrating epidermis cells are also called the
migrating epithelial tongue [16] or the migratory tongue.The
cellmigration terminates after themigrating epithelial tongue
bridges both sides of the wound edge [17].
The epithelial tongue and migratory tongue distances
were not significantly different between irradiated and nonir-
radiated wounds or between biomaterials (𝑃 > 0.05). This is
because the measurement of the epithelial tongue formation
and the migratory tongue distance were performed on day
7, which is considered a mature stage. Moreover, wound
contraction had already started five days after the injury
[18]. The combination of re-epithelialization and contraction
increases the length of the epithelial tongue and shortens the
migratory tongue distance. Therefore, an early assessment
of the epithelial tongue and migratory tongue distance,
for example, on day 4 is recommended to show a robust
difference.
The appearance of a scar is a clinical manifestation of the
remodelling stage of healing. It involves collagen synthesis,
degradation of the vascular and cellular components of scar
tissue, loss of scar tissue mass, and presentation of obvious
changes in the visual appearance of wound site [1]. Collagen
is deposited in the scar to strengthen the wound site and
is also degraded in an attempt to remodel the wound.
However, there is an imbalance between collagen deposition
and degradation. In certain cases, the collagen production
exceeds the collagen degradation, raising a thick scar [19].
However, wound healing can be manipulated to produce
more regenerative tissue and less scar formation by using
skin replacement products [20]. This study demonstrated
that the chitosan skin substitute and chitosan dermal sub-
stitute generate significant tissue-engineered skin with less
scaring than duoderm CGF (𝑃 < 0.05) when used in an
irradiated wound. In the nonirradiated wounds, the collagen
production was interfered due to aggressive behaviour of the
rats. They preferred to remove the dressing materials which
cause starched to the wound bed and resulting poor collagen
production.Thewounds with the damaged biomaterials were
not replaced with a new one, because a new biomaterial
replacement will enhance wound healing and create bias
to the experimental results. The irradiated rats were not
aggressive compared with the nonirradiated rats. Therefore,
the experimental results in the irradiated rats were consistent
compared to those in the nonirradiated rats.
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If the wound therapy is appropriate, on day 14, the wound
edge will be dry, the biomaterial will be incorporated into
the wound, and the amount of exudate must progressively
diminish.The color and odor of the wound exudate are often
used as indicators of wound infections. Pus (a yellow or green
exudate) is a result of excessive bacterial loads and the demise
of neutrophils after they have phagocytosed debris. Signs of
infection can be observed if the wound has greater than 105
bacteria. As a natural antimicrobial product, the chitosan
dermal substitute and chitosan skin substitute significantly
decreased the colonized bacterial growth in a full-thickness
wound. Moreover, both of these chitosan substitutes were
created as flexible elastic foams because of their ability to
conform in proportion to the applied force [21]. The ability
of a biomaterial to conform and return to its nominal shape
or thickness is important in support surface systems. These
two chitosans have been shown to be excellent hemostatic
agents both in irradiated and nonirradiated full-thickness
wounds.These findingswere observed as early as day 3 during
secondary dressing changes, wherewound hemorrhageswere
not present.The ability of these two chitosans to absorb excess
exudates may prevent trauma to the surrounding tissue.
K10 is a marker of differentiated epidermis. Its expression
is low on the wound edge, but it is highly expressed on the
migratory tongue adjacent to the wound [10]. K10 is not
expressed on the wound bed as the neoepidermis is still
proliferating and not fully differentiated or in a mature stage.
HLA expression confirmed the mutual xenotransplantation
incorporation with irradiated and nonirradiated wounds, as
early as day 7 as described previously [22].
Rats are themost favourite wound healing animal models
to recapitulate human physiology and forecast therapeutic
outcomes. Rats have been widely used because of their avail-
abilities, low cost, tractable nature, and ease of handling [23].
Additionally, established broad knowledge and promising
results based on rat wound healing earned from previous
studies are the main reason for rat utilizing. Inspired by the
previous good results of the inflammatory evaluation in the
rats treated with chitosan [24], we investigated the impact of
using chitosan dermal substitute and chitosan skin substitute
on impaired and nonimpaired wounds.
Irradiated rats have resulted in compromised skin
integrity which compromised wound healing in irradiated
tissue to lead the impede healing [25]. Meanwhile, the
nonirradiated rats are fully immunocompetent. To date,
human HFSCs cultured into chitosan have never been used
to repair the wound in immunocompetent model. There are
accumulative evidence of immunocompetent host tolerance
to xenogenic fibroblasts, mesenchymal, or epithelial cells and
they survived in the host for a few weeks [26–28]. The long-
term survival of xenogenic cells and their proliferation up to
fourmonths in the fully immunocompetent host without sign
of immune rejection have also been reported [29]. Fibroblasts
aremostly immunologically toleranst [30]. Xenogenic fibrob-
lasts have less tendency to tissue rejection as they expressed
HLAwithout inducing T-cell proliferation [31]. Bonemarrow
stem cells and mesenchymal stem cells (MSCs) have shown
the potential in vivo immune modulation and immune
privileged properties [32–35]. Additional studies suggest that
MSCs derived from human or animal express costimulatory
antigens which results in immunoprivileged [27, 36, 37]. As
none of the rats died of infection or presented with complica-
tion particularly at the wound site in the nonirradiated rats,
HFSCs-chitosan constructs are suggested less or not prone
to tissue rejection. The HFSCs resulted in immunoprivileged
which MSCs have done in cell or tissue therapy. Moreover,
the macroscopic image and physical observation of wounds
have shown the comparable inflammatory response both in
the irradiated or nonirradiated wounds. Since the rats were
immunocompetent, the positive results are predicted due to
the rat skin as an immunoprivileged site.
5. Conclusion
Theradiation procedure has leaded the full-thicknesswounds
to have impaired healing. Direct observation of temporary
hair loss on irradiated skin was present. In addition, his-
tology analysis has proved anatomical changes of sebaceous
gland as well as hair follicles. The use of chitosan der-
mal substitute and chitosan skin substitute has proven to
accelerate full-thickness wound healing in irradiated rats as
they significantly decreased the size of scar. The physical
observation of wound assessment has shown that both of
chitosan substitutes are ideal matrices for primary dressing.
The use of HFSCs-chitosan construct on immunocompetent
rat has shown their potential in vivo immunemodulation and
immune privileged properties.
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